Cryptococcus neoformans and Cryptococcus gattii cause life-threatening meningoencephalitis and pneumonia in immunosuppressed and immunocompetent individuals. Given the structural differences of major polysaccharide glucuronoxylomannan (GXM) between C. neoformans and C. gattii, it remains unclear that how innate immune system recognizes GXM. Here, we report that C-type lectin receptor Dectin-3 (MCL encoded by Clec4d) is a direct receptor for GXMs from C. neoformans serotype AD (C.n-AD) and C. gattii serotype B (C.g-B). GXMs from C.n-AD and C.g-B activated both NF-κB and ERK pathways to induce the pro-inflammatory cytokine production, whereas it was completely abolished due to deficiency of Dectin-3 or its downstream adaptor protein CARD9. Upon pulmonary C.n-AD and C.g-B infection, Dectin-3-and CARD9-deficient mice were highly susceptible and showed augmented lung injury due to impairment of alveolar macrophage accumulation and killing activities. These results demonstrate that Dectin-3 contributes to host immunity against Cryptococcus infection through selectively recognizing GXM. 
Introduction
The saprophytic, encapsulated fungal pathogens Cryptococcus neoformans and C. gattii can cause life-threatening meningoencephalitis and pneumonia in immunocompromised and immunocompetent individuals, which is called cryptococcosis [1] . C. neoformans has been classified into three serotypes including A, D, and AD hybrid whereas serotypes B and C have been recognized as a separate species called C. gattii based on antigenic differences in the polysaccharide capsules of the fungus [2] [3] [4] . C. neoformans serotype A (C.n-A) is the most clinically prevalent in immunocompromised individuals including HIV patients, renal transplant recipients and those undergoing immunosuppressive therapy [5] , whereas C. neoformans serotype D (C.n-D) is mostly found in Europe but has a sporadic global distribution [6] . A recent survey in Europe revealed that 19% of human infections are caused by C. neoformans serotype AD (C.n-AD), which is a hybrid of serotype A and D strains [7] . In contrast, infection by C. gattii including serotype B and C (C.g-B and
C.g-C)
is much less common in immunocompromised patients but is thought to be more virulent than C. neoformans and causes disseminated infections even in healthy hosts [8] . Previously, it was thought that C. gattii infections were restricted to tropical and subtropical regions [9] , but the emergence of the outbreak events due to C. gattii infections in temperate areas of North America suggest a more global distribution of this yeast [10, 11] .
Both C. neoformans and C. gattii are found ubiquitously in soil and other niches, and inhalation of yeast or desiccated basidiospores into the lungs is extremely common, causing about 70% of children with pulmonary infections in urban environments [12] . Host immune cells including alveolar macrophages and dendritic cells recognize pathogen associated molecular patterns (PAMPs) via pattern recognition receptors (PRRs), which elicit the host defense response. C-type lectin receptors (CLRs), a PRR-recognizing PAMP composed of polysaccharides, have garnered the attention of many investigators in the study of host defense against fungal infection [13, 14] . The genetic deficiency of Dectin-1, a representative CLR recognizing β1,3-glucans of Candida albicans yeast and Aspergillus fumigatus conidia [15, 16] , did not influence the clearance of C.n-A pulmonary infections [17] .
Dectin-2 is known to recognize α-1,2-mannans of C. albicans and A. fumigatus hyphae, lipophilic and hydrophilic components of Malassezia, mannose-capped lipoarabinomannan of Mycobacterium tuberculosis and unknown components of non-capsular C.n-A to trigger the production of various cytokines and chemokines, including pro-inflammatory Th1, Th17, and also Th2 cytokines [18] [19] [20] [21] [22] .
Our earlier studies show that Dectin-3 (also called CLECSF8, MCL, or Clec4d) can recognize α-1,2-mannans of C. albicans hyphae and trehalose 6,6'-dimycolate (TDM)
of M. tuberculosis [23, 24] . However, a recent study shows that Dectin-3 is dispensable for mediating protective immune responses against pulmonary C.n-A infection [25] .
The genetic defect of the caspase recruitment domain family member 9 (CARD9), an adaptor protein that operates downstream of CLRs for activating NF-κB and extracellular signal-regulated protein kinase (ERK) pathways [26, 27] , confers susceptibilities to pulmonary C.n-A infection probably due to the reduced accumulation of IFN-γ-expressing NK and memory T cells [28] .
Cryptococcal capsule is composed primarily of glucuronoxylomannan (GXM), which comprises more than 90% of the capsule's polysaccharide mass [29] . . The ability of GXM to activate the Toll-like receptor (TLR)-mediated innate immune response has been reported in several studies [34] [35] [36] . In detail, GXM from C.n-A activates TLR4-mediated intracellular signaling
[34], but its contribution to the global innate response against C. neoformans infections is limited [37, 38] . GXM from C.n-A can also interact with TLR2 [34], which is believed to influence the response to cryptococcal infection [35] . A recent study shows that GXM from five cryptococcal serotypes were differentially recognized by TLR2/TLR1 and TLR2/TLR6 heterodimers [36] . Overall, most studies 6 on the immunological functions of GXM have focused on the polysaccharide fractions from C.n-A isolates. Given the structural differences of GXM among the five serotypes, it also remains unknown that how host innate immune system differentially recognizes these GXMs.
In the present study, we show that Dectin-3 is a direct receptor for capsular GXM from C.g-B and C.n-AD, but not C.n-A, C.n-D and C.g-C. Furthermore, we demonstrate that Dectin-3 is essential for GXM-induced inflammatory responses through activating NF-κB and ERK pathways. Therefore, Dectin-3-deficient mice are highly sensitive to pulmonary C. g-B and C.n-AD infections due to impairment of alveolar macrophage activation.
Results

Dectin-3 recognizes the capsule of C.g-B to induce NF-κB and ERK-mediated pro-inflammation responses
In nature and under laboratory conditions, the capsule of Cryptococcus strains is relatively thin but can be mature to become thick during mammalian infection [39] . In this study, C.g-B strain ATCC32609 was prepared as thin-and thick-capsulated suspensions as described [39] and capsule induction was confirmed by India ink staining ( Figure 1A) . To explore whether Dectin-3 is required for C.g-B induced
pro-inflammation responses, we stimulated bone marrow derived macrophages (BMDMs) from wild-type (WT, Clec4d +/+ ) and Dectin-3 deficient (Clec4d Furthermore, we found that secretion of pro-inflammation cytokines including TNF-α and IL-6 were increased in WT BMDMs when stimulated with thin-and thick-capsulated C.g-B, whereas Dectin-3 deficiency significantly impaired these responses ( Figure 1D) . However, C.g-B-induced levels of IL-12p40 and IL-1β were comparable in WT and Dectin-3 deficient BMDMs ( Figure 1D ). These results suggest that Dectin-3 is essential for C.g-B-induced NF-κB and ERK-mediated pro-inflammation responses.
During cryptococcal infection, various chemokines are produced by alveolar monocytes to attract inflammatory cells and specific leukocyte subsets from blood to the site of infection. Here, we found that Dectin-3 deficiency in BMDMs strikingly impaired C.g-B-induced expression of CCL5/RANTES and of C-X-C motif chemokine ligand 9 (CXCL9) and CXCL10 ( Figure 1E) , which can attract activated T cells (particularly Th1 cells), dendritic cells, and monocytes by binding to specific CC chemokine receptors (CCR) on these cells, including CCR5 and CXCR3
[28]. However, there were slight influences of Dectin-3 deficiency on C.g-B-induced expression of CCL1, CXCL-1, macrophage inflammatory protein-1α (MIP-1α),
MIP-1β, MIP-2, monocyte chemotactic protein-1 (MCP-1), granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF and M-CSF in BMDMs ( Figure 1E ).
These results suggest that Dectin-3 is also essential for C.g-B-induced NF-κB and ERK-mediated chemokine productions, resulting in the formation of granulomas and activation of adaptive immunity.
To explore whether Dectin-3 can bind the surface capsule of C.g-B, we 
Dectin-3 recognizes the capsule of C.n-AD to induce pro-inflammation responses
A recent study shows that Dectin-3 is not required for mediating protective immune responses against pulmonary C.n-A infection [25] . Here, we found that stimulation with C.n-A failed to induce the production of pro-inflammation cytokines including TNF-α, IL-6, IL-12p40 and IL-1β in WT and Dectin-3 deficient BMDMs (Figure 2A) . However, stimulation with C.n-AD, C.g-C and C.n-D could induce large amounts of pro-inflammation cytokines including TNF-α and IL-12p40 in WT BMDMs whereas C.n-AD stimulation induced IL-6 and IL-1β production ( Figure   2A ). Of note, Dectin-3 deficiency significantly impaired the production of TNF-α, IL-6 and IL-12p40 in BMDMs when stimulated with both thin-and thick-capsulated C.n-AD, but not C.g-C and C.n-D (Figure 2A) . As controls, Dectin-3 deficiency only affected TNF-α and IL-6 secretion in BMDMs when stimulated with another C.g-B strain WM179 (Figure 2A) . Unexpectedly, Dectin-3 deficiency had no influence on the IL-1β production when stimulated with C.n-AD and C.g-B (Figure 2A) . These results suggest that Dectin-3 is also critical for mediating pro-inflammation responses induced by C.n-AD, but not C.n-A, C.n-D and C.g-C.
Furthermore, we performed FACS screening assay to examine the binding of Dectin-3 recognizes GXM from C.g-B and C.n-AD to induce NF-κB-and
ERK-mediated pro-inflammation responses
To further determine whether Dectin-3 recognizes GXM from C.g-B and C.n-AD to elicit pro-inflammation responses, we stimulated wild-type and Dectin-3-deficent
BMDMs with plate-coated GXM extracted from C.g-B (GXM-B) and C.n-AD (GXM-AD). We found that stimulation with plate-coated GXM-B and GXM-AD induced IBα phosphorylation and degradation and ERK phosphorylation ( Figure 4A and 4B). In contract, Dectin-3 deficiency in BMDMs strikingly impaired GXM-B or GXM-AD induced activation of NF-κB and ERK pathway (Figure 4A and 4B) .
Furthermore, we found that only stimulation with plate-coated GXM-B and GXM-AD potently induced the secretion of pro-inflammation cytokines including TNF-α, IL-6
and IL-12p40 whereas Dectin-3 deficiency significantly impaired these responses ( Figure 4C ). We further examined the effect of inhibiting NF-κB or ERK signaling on pro-inflammation cytokine production by wild-type BMDMs. We found that treatment with TPCA, a specific inhibitor for NF-κB activation, significantly suppressed TNF and IL-6 production by wild-type BMDMs when stimulated with plate-coated GXM extracted from either C.g-B or C.n-AD ( Figure 4E and 4F).
However, treatment with U0126, an inhibitor for ERK activation, only blocked TNF production and had no inhibitory effect on GXM-induced IL-6 production ( Figure 4E and 4F). Thus, these data suggest that Dectin-3 recognizes GXM from C.g-B and
C.n-AD to trigger NF-κB-and ERK-mediated pro-inflammation responses.
Dectin-3-deficient mice are highly susceptible to pulmonary infection with C.g-B and C.n-AD
To provide genetic evidence that Dectin-3 plays a critical role against experimental pulmonary cryptococcosis, we explored the overall impact of Dectin-3 deficiency during an experimental pulmonary infection with C.g-B and C.n-AD in mice. WT and Dectin-3 deficient mice received an intratracheal inoculation with C.g-B strain ATCC32609. Survival was monitored for greater than 60 days post-inoculation, while pulmonary fungal burden was evaluated in a separate group of infected mice at select time points post-inoculation ( Figure 5A and 5B). We found that all infected Dectin-3 deficient mice died during 45 days, whereas about 70% infected WT mice survived for more than 65 days (p < 0.01, Figure 5A ). Consistently, the burdens of C.g-B in lung and brain on day 3 after infection were significantly higher in Dectin-3 deficient mice than in WT mice (p < 0.01 and p < 0.001 respectively, Figure 5B ). We then conducted a histological analysis of the lungs on day 14 after infection. Massive multiplication of yeast cells with poor granulomatous responses was observed in the alveolar spaces of Dectin-3 deficient mice, whereas WT mice showed a seldom number of yeast cells, which were mostly encapsulated in the granulomatous tissues ( Figure 5C ). We also detected the significant reductions of pro-inflammatory cytokine including TNF-α and IL-6 in the lungs of Dectin-3 deficient mice than those in WT mice ( Figure 5D ). However, the amount of IL-12p40
and IL-1β was not significantly decreased in the lungs of Dectin-3 deficient mice 
CARD9 is critical for pro-inflammation responses induced by GXMs
It has been shown that CARD9 operates downstream of CLRs for activating NF-κB and ERK pathways [26, 27] . To explore whether CARD9 is required for Figure S4E ), which has been reported in a previous study [28] . Moreover, CARD9 deficient mice exhibited higher fungal burdens in lungs than WT mice after intratracheal infection with C.n-AD strain WM628, C.g-C strain NIH312 and C.n-D strain WM629 for 3 days (p < 0.01, Figure   7F ). However, there were no differences in lung fungal burdens between WT and CARD9 deficient mice when infected with C.n-A strain H99 on day 3 ( Figure 7F ). Thus, Dectin-3-mediated signaling was demonstrated to be critical for rendering the host defense against pulmonary infection with C.g-B and C.n-AD. Nonetheless, we observed no defect in the capacity of Dectin-3-deficient mice to combat experimental pulmonary infections with C. n-A, C. n-D or C. g-C, which is in line with the previous study [25] . Thus, our results suggest that the role of Dectin-3 for host defense against cryptococcosis is specific to Cryptococcus serotypes. However, Dectin-1, which recognizes β-1,3-glucans in a variety of fungi including C. albicans [15] , is not required for protection against pulmonary C. n-A infection [17] . Dectin-2 is postulated to induce Th2-type responses and IL-4-dependent mucin production in the lungs following infection with C. n-D [20] . The impact of Dectin-1 or Dectin-2 deficiency may also vary depending on the Cryptococcus serotypes.
Cryptococcus strains possess the large polysaccharide capsule to shield its cell wall components and the capsule is primarily composed of GXM, which comprises more than 90% of the capsular polysaccharide mass [29] . The cell wall of
Cryptococcus strains is composed of chitin, chitosan, glucans and glycoproteins. Thus, carbohydrates present in the capsule and cell wall of Cryptococcus strains are ideal
PAMPs for recognition by Dectin-3. Our present study showed that Dectin-3 could directly recognize the capsular GXM extracted from C. g-B or C. n-AD strains.
Monosaccharide composition analysis showed the quantity and position of xylose In conclusion, we have extensively characterized the role of Dectin-3 and CARD9 during pulmonary cryptococcosis using an experimental murine model of pulmonary infection with C. neoformans and C. gattii. Upon pulmonary C.n-AD and C.g-B infection, Dectin-3-and CARD9-deficient mice were highly susceptible and showed augmented lung injury due to impairment of AM accumulation and killing activities, and subsequent productions of pro-inflammation cytokines and chemokines.
More importantly, we showed that Dectin-3 directly recognized GXMs from C.n-AD and C.g-B to activate CARD9-mediated NF-κB and ERK pathways for initiating anti-fungal host responses against C. neoformans and C. gattii (Figure 8) . Thus, our study provides the first biological and genetic evidence demonstrating that Dectin-3
recognizes GXM of C. neoformans serotype AD and C. gattii serotype B to initiate host defense against cryptococcosis.
Materials and Methods
Cryptococcus strain. BMDM preparation. Primary cultures of BMDMs from C57B/L6 mice were prepared as previously described [43] . Briefly, bone marrow cells were harvested from the femurs and tibias of mice. Erythrocytes were removed from cells by using a hypotonic solution. Cells were cultured for 7 days in DMEM medium containing 20% fetal bovine serum, 50 mM β-mercaptoethanol, 100μg/mL penicillin-streptomycin, and 30% conditioned medium from L929 cells expressing M-CSF. On day 3, another 10 ml of the same medium was added. On day 7, non-adherent cells were removed, and adherent cells were harvested.
Chemokine assay. Total RNA was extracted from the infected lungs or BMDMs using Triozl (TaKaRa Bio, Otsu, Japan), and the first-strand cDNA was synthesized using PrimeScript first-strand cDNAsynthesis kit (TaKaRa Bio, Otsu, Japan), according to the manufacturer's instructions. Quantitative real-time PCR was performed in a volume of 20 μl using gene-specific primers and SYBR Premix Ex TaqII (TaKaRa Bio, Otsu, Japan) in a ABI 7500 system (Applied Biosystems, USA).
The amounts of transcript were normalized to GAPDH. ∆∆Ct method to calculate fold Isolation and purification of GXM. The extracted extracellular polysaccharides (EPS) from Cryptococcus strains were isolated as previously described [44] . In detail, strains were grown in YNB culture medium at 30°C with shaking for 4 days and then the supernatant were collected after centrifuging with 7500 rpm for 5min. The supernatant was slowly added with 3 volumes of EtOH and incubated for overnight at 4°C, which were centrifuged at 7500 rpm for 10min. The precipitate was collected for air dry and then dissolved into 18 mL ddH 2 O. The polysaccharide concentration was determined by the phenol sulfuric method of Dubois (data not shown). To purify GXM, the polysaccharide solution was adjusted to 0.2M NaCl and finalized with 3 times (w/w) of 0.3% (w/v) CTAB solution at room temperature, the mixture of which is named as CTAB-GXM. Then, CTAB-GXM was centrifuged at 9000 rpm for 10 min and the precipitate of CTAB-GXM was washed with 10% EtOH in ddH20 (v/v).
To remove CTAB, the precipitate of CTAB-GXM was dissolved in 1 M NaCl and finalized with about 2.5 times (v/v) of EtOH with stirring. The precipitate containing GXM was collected after centrifuging at 9000 rpm for 10 min at room temperature and then dissolved in 2 M NaCl until a viscous solution forms. The viscous solution was dialyzed in a dialysis cassette with a 10,000 MW cutoff for overnight against 1 M NaCl and then against fresh ddH 2 O for 1 week. Finally, the solution EPS containing GXM inside the dialysis bag was lyophilized at -55°C for overnight. Endotoxin levels of GXM were measured by endotoxin assay kit (GenScript, Cat. No. L00350C).
Analysis of monosaccharide composition of GXM. EPS (1mg) was hydrolyzed with
2 M TFA at 120°C for 2h. After repeated evaporation with methanol to completely remove TFA, the residue was dissolved in distilled water and reduced with NaBH 4 at room temperature for 3h. After neutralization with AcOH and evaporation to dryness, the residue was acetylated with Ac 2 O for 1h at 100°C. The resulting alditol acetates were analyzed with gas chromatography-mass spectrometry (GC-MS). The GC-MS temperature program for monosaccharide analysis was as follows: 140-198°C at 2°C /min, maintained for 4 min and increased to 214°C at 4°C /min, followed by increases of 1°C /min until 217°C was reached, which was maintained for 4 min and finally increased to 250°C at 3°C/min, maintained for 5 min as reported previously [45] . and NaBH4 for carboxyl reduction [46] . This procedure resulted in D-glucuronic acid converted into D-glucose. For deacylation, EPS (25mg) was treated with 5 ml NaOH (0.1M) for 16h at 37°C, neutralized with 0.1M HCl, and then dialyzed against water [47] . For partial acid hydrolysis, EPS (50 mg) was hydrolyzed in 5ml TFA (0.1M) and incubated at 100°C for 1h. The hydrolysate solution was evaporated to remove TFA through repeated evaporation with MeOH under reduced pressure [45] .
NMR analysis. EPS (80 mg) was dissolved in 0.4 ml D 2 O (99.8 Atom% Deuterium;
Schweres Wasser, USA were recorded, and data were processed using standard Bruker software and MestReNova [48] .
Expression of fusion protein.
The hCLRs-pFUSE-hIgG1-Fc vectors were then transfected into 293T using Lipo2000 (Sigma), one days later, adding bleomycin (invivoGen), the best proportion of bleomycin VS. DMEM is 3:1000. After culturing three days, the cell supernatant was collected and the expression of CLR-Fc fusion protein was determined by immunoblot analysis with anti-Fc antibody.
FACS.
Yeast cells underwent lag phase induction and were plated at 1×10 7 cells/tube.
Staining was performed in 0.5% BSA in PBS. Fusion proteins were then applied at Fungal burden analysis. Mice were sacrificed on day 3 after infection, and lungs or brains were dissected carefully, excised, and then homogenized separately in 1ml of distilled water by teasing with a stainless mesh at room temperature. The homogenates, diluted appropriately with distilled water, were inoculated at 100μl on SDA plates and cultured for 2 days, and the resulting colonies were counted.
Histological examination. The lung specimens obtained from mice were fixed in 10% buffer formalin, dehydrated, and embedded in paraffin. Sections were cut and stained with hematoxylin-eosin (H-E) or gomori's methenamine silver (GMS) stain, using standard staining procedures, at pathology platform of Servicebio Technology, Wuhan, China. 
GXM-
